Invest in SPDR S&P Biotech ETF (XBI) for long-term growth potential and diverse, equal-weighted portfolio in the biotech ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

We recently compiled a list of the 12 Stocks That Will Double in 2025. In this article, we are going to take a look at where ...

Clinical-stage biopharmaceutical company Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining significant attention from investors ...

The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go ...

Cargo Therapeutics, a Bay Area biotech firm, is laying off half its staff after having to shut down a promising drug ...

Shares in clinical-stage biotechnology company Cargo Therapeutics (CRGX) have plunged after it scrapped trials of a cancer ...

In this article, we will take a look at the 12 stocks that will double in 2025.

We recently compiled a list of the 12 Stocks That Will Double in 2025. In this article, we are going to take a look at where ...

Was it a good idea to invest $1,000 into Mesoblast Ltd (ASX: MSB) shares at the start of last year? Let's see what it would ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech ...